trial,pubID,pseudogroup,weeks,group,IgD-/IgM-/IgA-/IgG+/KO-/Antigen++ B cells
G002,G002-794,,-5,4,55.0
G002,G002-396,,-5,4,57.0
G002,G002-365,,-5,4,70.0
G002,G002-387,,-5,4,43.0
G002,G002-104,,-5,4,17.0
G002,G002-489,,-5,4,7.0
G002,G002-611,,-5,4,43.0
G002,G002-710,,-5,4,64.0
